Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data
Cancers · 08.04.2026 · 18 (8) · 1190
DOI: 10.3390/cancers18081190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 08.04.2026. Verfasst von Xueting Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shanghai Science and Technology Innovation Action Plan in Computational Biology, Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai.
Abstract (Originalsprache)
Objectives
Platinum resistance remains a critical bottleneck in ovarian cancer management, yet reliable pre-treatment predictive tools are lacking. Existing markers like the platinum-free interval are retrospective, while genomic profiling is often cost-prohibitive. This study aimed to develop an accessible, machine learning-based dynamic weighted fusion (DWF) model using routine laboratory data to provide bidirectional risk stratification, particularly to reliably rule out platinum resistance before treatment initiation.
Methods
In this retrospective study (2019–2023), seventy baseline clinical features were collected to differentiate platinum-resistant from platinum-sensitive ovarian cancer patients. We developed a DWF framework that dynamically integrates the top-performing classifiers from a library of 168 algorithms (combining 14 feature selection and 12 machine learning methods). Class imbalance was addressed via oversampling, and model efficacy was evaluated using area under the curve (AUC), accuracy, sensitivity, and specificity.
Results
The DWF model achieved a robust AUC of 0.760 (95% CI: 0.683–0.837), outperforming all individual base classifiers. Subgroup analysis demonstrated highly consistent overall discrimination across initial treatment strategies (AUC of 0.755 for primary debulking surgery and 0.761 for neoadjuvant chemotherapy). Feature interpretation highlighted that resistance is driven by synergistic dysregulation of systemic inflammation and hypercoagulability, rather than single biomarkers.
Conclusions
The proposed DWF model effectively leverages low-cost, standardized clinical data to serve as a robust bidirectional stratification tool. Its exceptional ability to rule out resistance provides clinicians with the evidence-based confidence to proceed with standard therapies, while its high-risk alerts identify candidates for early therapeutic adjustments and enhanced surveillance in ovarian cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
- Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- Intelligent Medicine Institute, Fudan University, Shanghai 200032, China.
- Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai 200120, China.
ORCID-Profile: Yangyang Zhang
Förderung
- National Key Research and Development Program of China
- Shanghai Science and Technology Innovation Action Plan in Computational Biology
- Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai
Zitieren
APA
Peng, X., Zhang, Y., Zhu, C., Chen, W., Wu, X., Zhong, F., Guo, Q., & Liu, L. (2026). Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data. Cancers, 18(8), 1190. https://doi.org/10.3390/cancers18081190
Vancouver
Peng X, Zhang Y, Zhu C, Chen W, Wu X, Zhong F, et al. Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data. Cancers. 2026;18(8):1190. doi:10.3390/cancers18081190
BibTeX
@article{Peng2026,
author = {Peng, Xueting and Zhang, Yangyang and Zhu, Chaoyu and Chen, Weijie and Wu, Xiaohua and Zhong, Fan and Guo, Qinhao and Liu, Lei},
title = {Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data},
journal = {Cancers},
year = {2026},
volume = {18},
number = {8},
pages = {1190},
doi = {10.3390/cancers18081190}
}
EUVIMED